Nicotine Patch, Extended Release
Product Images NDC 63868-734

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 63868-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Marketing Association Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Step1 (Step 1 14ct Carton)

Nicotine Transdermal System Patch 21 mg, extended release, delivered over 24 hours, for smoking cessation aid. The label indicates Step 1 in the treatment program and includes 14 patches (a 2-week kit). It features usage instructions, warnings, inactive ingredients, and contact information from Chain Drug Marketing Association Inc. The package emphasizes a behavior support program and provides guidance based on daily cigarette use.*

FDA Label Image

Step2 (Step 2 14ct Carton)

Nicotine Transdermal System Patch 14 mg delivered over 24 hours, Step 2 strength, extended-release transdermal patch for smoking cessation by Chain Drug Marketing Association INC. The carton highlights a 14-patch two-week kit with a behavior support program and self-help guide. Drug facts, warnings, directions, and storage instructions are included on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.